On April 24, 2025, IO Biotech, Inc. issued a Tranche A warrant as part of a €57.5 million financing agreement, allowing the European Investment Bank to purchase up to approximately 5.6 million shares at $0.8891 each. The first tranche of €10 million is expected to be drawn on May 6, 2025.